Home › Funds › FIDUCIARY TRUST CO › ABT

FIDUCIARY TRUST CO position in ABT

ABBOTT LABORATORIES · Health Care

FIDUCIARY TRUST CO reported holding 354,249 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$32.1M, representing 0.35% of its reported portfolio and ranking #47 among its reported holdings. FIDUCIARY TRUST CO has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)354.25K sh
Reported value held$32.14M
Portfolio Weight0.35%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FIDUCIARY TRUST CO's ABT position evolved

FIDUCIARY TRUST CO first disclosed a stake in ABT in Q3 2023 at 312,020 shares (US$30.2M). The position peaked in Q3 2025 at 377,273 shares, worth US$50.5M. Across 12 filings, FIDUCIARY TRUST CO increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 354,249 shares valued at US$32.1M — a reduction of -6,281 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 312.02K $30.22M New
Q4 2023 308.03K $33.90M Reduce
Q1 2024 306.48K $34.83M Reduce
Q2 2024 305.58K $31.75M Hold
Q3 2024 301.86K $34.41M Reduce
Q4 2024 308.63K $34.91M Add
Q1 2025 374.79K $49.72M Add
Q2 2025 371.21K $50.49M Reduce
Q3 2025 377.27K $50.53M Add
Q4 2025 375.20K $47.01M Reduce
Q1 2026 360.53K $37.02M Reduce
Q2 2026 354.25K $32.14M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has FIDUCIARY TRUST CO held ABT?

FIDUCIARY TRUST CO has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is FIDUCIARY TRUST CO's current position in ABT?

As of Q2 2026, FIDUCIARY TRUST CO holds 354.25K shares of ABT (ABBOTT LABORATORIES), valued at $32.14M, representing 0.35% of its reported portfolio and ranking #47.

Has FIDUCIARY TRUST CO been buying or selling ABT?

In the latest 13F filing (Q2 2026), FIDUCIARY TRUST CO reduced its position in ABT. The position peaked in Q3 2025 at 377.27K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.